Current status of artificial o2 carriers

Anesthesiology Clinics of North America

Volumn 23, Issue 2, 2005, Pages 373-389

  Thyes, Caroline ^a   Spahn, Donat R ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

DIASPIRIN CROSSLINKED HEMOGLOBIN; FLUOROCARBON; HEMOGLOBIN; LIPOSOME; MP 4; PERFLUOROOCTYL BROMIDE; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN;

ABDOMINAL PAIN; BLOOD DONOR; CLINICAL TRIAL; CROSS LINKING; DRUG EFFICACY; DRUG HALF LIFE; DRUG STABILITY; DRUG TOLERABILITY; DRUG TRANSPORT; DYSPHAGIA; EMULSION; ERYTHROCYTE TRANSFUSION; ESOPHAGUS DISEASE; FEVER; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEMODILUTION; HEMOGLOBIN DETERMINATION; HEMORRHAGIC HYPOTENSION; HUMAN; HYPERTENSION; ILEUS; JAUNDICE; MYALGIA; NAUSEA AND VOMITING; NEPHROTOXICITY; NONHUMAN; OLIGURIA; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; OXYGEN TENSION; OXYGEN TRANSPORT; PANCREATITIS; PHYSICAL CHEMISTRY; PRION DISEASE; REVIEW; URINARY TRACT DISEASE; VIRUS INACTIVATION;

EMULSIONS; ERYTHROCYTE TRANSFUSION; FLUOROCARBONS; HEMOGLOBINS; HUMANS; LIPOSOMES; OXYGEN; RECOMBINANT PROTEINS;

EID: 19744370719     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2005.01.004     Document Type: Review

References (98)

1. A.G. Greenburg Benefits and risks of blood transfusion in surgical patients World J Surg 20 1996 1189 1193
2. M. Casutt, B. Seifert, and T. Pasch Factors influencing the individual effects of blood transfusion on oxygen delivery and oxygen consumption Crit Care Med 27 1999 2194 2200
3. S. Kleinman, P. Chan, and P. Robillard Risks associated with transfusion of cellular blood components in Canada Transfus Med Rev 17 2003 120 162
4. C.A. Llewelyn, P.E. Hewitt, and R.S. Knight Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion Lancet 363 2004 417 421
5. F. Houston, J.D. Foster, and A. Chong Transmission of BSE blood transfusion in sheep Lancet 356 2000 999 1000
6. A. Aguzzi, and M. Glatzel vCJD tissue distribution and transmission by transfusion: a worst-case scenario coming true? Lancet 363 2004 411 412
7. C. Marcucci, C. Madjdpour, and D.R. Spahn Allogeneic blood transfusions: benefit, risks and clinical indications in countries with a low or high human development index Br Med Bull 31, 70 2004 15 28
8. L.T. Goodnough, M.E. Brecher, and M.H. Kanter Transfusion medicine. First of two parts: blood transfusion N Engl J Med 340 1999 438 447
9. C.C. Silliman, L.K. Boshkov, and Z. Mehdizadehkashi Transfusion-related acute lung injury: epidemiology and a prospective analysis of etiologic factors Blood 101 2003 454 462
10. L.T. Goodnough Risks of blood transfusion Crit Care Med 31 12 Suppl 2003 S678 S686
11. D.L. Malone, J. Dunne, and J.K. Tracy Blood transfusion, independent of shock severity, is associated with worse outcome in trauma J Trauma 54 2003 898 905
12. P.C. Hebert, G. Wells, and M.A. Blajchman A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care N Engl J Med 340 1999 409 417
13. J.L. Vincent, J.F. Baron, and K. Reinhart Anemia and blood transfusion in critically ill patients JAMA 288 2002 1499 1507
14. H.L. Corwin, A. Gettinger, and R.G. Pearl The CRIT Study: anemia and blood transfusion in the critically ill: current clinical practice in the United States Crit Care Med 32 2004 39 52
15. A.F. Shorr, M.S. Duh, and K.M. Kelly Group CS: red blood cell transfusion and ventilator-associated pneumonia: a potential link? Crit Care Med 32 2004 666 674
16. E.C. Vamvakas, and J.H. Carven Allogeneic blood transfusion, hospital charges, and length of hospitalization: a study of 487 consecutive patients undergoing colorectal cancer resection Arch Pathol Lab Med 122 1998 145 151
17. K. Birchard Ireland's blood shortage reaches crisis Lancet 351 1998 1567
18. D.R. Spahn, and M. Casutt Eliminating blood transfusions: new aspects and perspectives Anesthesiology 93 2000 242 255
19. L.T. Goodnough, M.E. Brecher, and M.H. Kanter Transfusion medicine. Second of two parts: blood conservation N Engl J Med 340 1999 525 533
20. C.P. Stowell, J. Levin, and B.D. Spiess Progress in the development of RBC substitutes Transfusion 41 2001 287 299
21. W.T. Phillips, R.W. Klipper, and V.D. Awasthi Polyethylene glycol-modified liposome-encapsulated hemoglobin: a long circulating red cell substitute J Pharmacol Exp Ther 288 1999 665 670
22. R. Rabinovici, A.S. Rudolph, and J. Vernick Lyophilized liposome encapsulated hemoglobin: evaluation of hemodynamic, biochemical, and hematologic responses Crit Care Med 22 1994 480 485
23. D.R. Spahn, B.J. Leone, and J.G. Reves Cardiovascular and coronary physiology of acute isovolemic hemodilution: a review of nonoxygen-carrying and oxygen-carrying solutions Anesth Analg 78 1994 1000 1021
24. Y. Huang, S. Takeoka, and H. Sakai Complete deoxygenation from a hemoglobin solution by an electrochemical method and heat treatment for virus inactivation Biotechn Progr 18 2002 101 107
25. R.M. Winslow Current status of blood substitute research: towards a new paradigm J Intern Med 253 2003 508 517
26. M.K. Viele, R.B. Weiskopf, and D. Fisher Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics Anesthesiology 86 1997 848 858
27. A.N. Schechter, and M.T. Gladwin Hemoglobin and the paracrine and endocrine functions of nitric oxide N Engl J Med 348 2003 1483 1485
28. A. Gulati, A.C. Sharma, and G. Singh Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin Crit Care Med 24 1996 137 147
29. A. Gulati, and S. Rebello Role of adrenergic mechanisms in the pressor effect of diaspirin cross-linked hemoglobin J Lab Clin Med 124 1994 125 133
30. R.J. Rohlfs, E. Bruner, and A. Chiu Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide J Biol Chem 273 1998 12128 12134
31. R. Migita, A. Gonzales, and M.L. Gonzales Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers J Appl Physiol 82 1997 1995 2002
32. M. Intaglietta, P.C. Johnson, and R.M. Winslow Microvascular and tissue oxygen distribution Cardiovasc Res 32 1996 632 643
33. K.D. Vandegriff, A. Malavalli, and J. Wooldridge MP4, a new nonvasoactive PEG-Hb conjugate Transfusion 43 2003 509 516
34. G.I. Kemming, F.G. Meisner, and M. Kleen Hyperoxic ventilation at the critical haematocrit Resuscitation 56 2003 289 297
35. J. van Bommel, A. Trouwborst, and L. Schwarte Intestinal and cerebral oxygenation during severe isovolemic hemodilution and subsequent hyperoxic ventilation in a pig model Anesthesiology 97 2002 660 670
36. M. Kleen, O. Habler, and J. Hutter Normovolaemic haemodilution and hyperoxia have no effect on fractal dimension of regional myocardial perfusion in dogs Acta Physiol Scand 162 1998 439 446
37. A.G. Tsai, P. Cabrales, and R.M. Winslow Microvascular oxygen distribution in awake hamster window chamber model during hyperoxia Am J Physiol 285 2003 H1537 H1545
38. J. Meier, G.I. Kemming, and H. Kisch-Wedel Hyperoxic ventilation reduces 6-hour mortality at the critical hemoglobin concentration Anesthesiology 100 2004 70 76
39. D.R. Spahn, R. van Bremt, and G. Theilmeier Perflubron emulsion delays blood transfusion in orthopedic surgery Anesthesiology 91 1999 1195 1208
40. D.R. Spahn, K. Waschke, and T. Standl Use of perflubron emulsion to decrease allogeneic blood transfusion in high-blood loss non-cardiac surgery: results of a European phase 3 study Anesthesiology 97 2002 1338 1349
41. F.J. Carmichael, A.C. Ali, and J.A. Campbell A phase I study of oxidized raffinose cross-linked human hemoglobin Crit Care Med 28 2000 2283 2292
42. Z. Ma, T.G. Monk, and L.T. Goodnough Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests Clin Chem 43 1997 1732 1737
43. A.A. Ali, G.S. Ali, and J.M. Steinke Co-oximetry interference by hemoglobin-based blood substitutes Anesth Analg 92 2001 863 869
44. A. Wolthuis, D. Peek, and R. Scholten Effect of the hemoglobin-based oxygen carrier HBOC-201 on laboratory instrumentation: cobas integra, chiron blood gas analyzer 840, Sysmex SE-9000 and BCT Clin Chem Lab Med 37 1999 71 76
45. F. Lurie, B. Driessen, and J.S. Jahr Validity of arterial and mixed venous oxygen saturation measurements in a canine hemorrhage model after resuscitation with varying concentrations of hemoglobin-based oxygen carrier Anesth Analg 96 2003 46 50
46. J.A. Wahr, M.M. Anderson, and D.A. Giacherio The effects of a blood-salvaging device on blood containing a hemoglobin-based oxygen carrier, HBOC-201 J Cardiothorac Vasc Anesth 11 1997 10 12
47. A.J. Reppucci, C. Mattia Goldberg, and R.J. Przybelski The effects of diaspirin-crosslinked hemoglobin on the assessment of immunohematology profiles Transfusion 37 1997 1143 1148
48. R. Chatterjee, E.V. Welty, and R.Y. Walder Isolation and characterization of a new hemoglobin derivative cross-linked between the alpha chains (lysine 99 alpha 1-lysine 99 alpha 2) J Biol Chem 261 1986 9929 9937
49. A.W. Sielenkämper, I.H. Chin Yee, and C.M. Martin Diaspirin crosslinked hemoglobin improves systemic oxygen uptake in oxygen supply-dependent septic rats Am J Respir Crit Care Med 156 1997 1066 1072
50. O. Habler, M. Kleen, and A. Pape Diaspirin-crosslinked hemoglobin reduces mortality of severe hemorrhagic shock in pigs with critical coronary stenosis Crit Care Med 28 2000 1889 1898
51. M.L. Lamy, E.K. Daily, and J.-F. Brichant Randomized trial of Diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery Anesthesiology 92 2000 646 656
52. A. Schubert, R.J. Przybelski, and J.F. Eidt Diaspirin-crosslinked hemoglobin reduces blood transfusion in noncardiac surgery: a multicenter, randomized, controlled, double-blinded trial Anesth Analg 97 2003 323 332
53. E.P. Sloan, M. Koenigsberg, and D. Gens Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial JAMA 282 1999 1857 1864
54. T. Kerner, O. Ahlers, and S. Veit DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" multicenter study Intensive Care Med 29 2003 378 385
55. S.J. Hoffman, D.L. Looker, and J.M. Roehrich Expression of fully functional tetrameric human hemoglobin in Escherichia coli Proc Natl Acad Sci USA 87 1990 8521 8525
56. D. Looker, D. Abbott-Brown, and P. Cozart A human recombinant haemoglobin designed for use as a blood substitute Nature 356 1992 258 260
57. J.H. Siegel, M. Fabian, and J.A. Smith Use of recombinant hemoglobin solution in reversing lethal hemorrhagic hypovolemic oxygen debt shock J Trauma 42 1997 199 212
58. J.S. Olson, E.W. Foley, and C. Rogge No scavenging and the hypertensive effect of hemoglobin-based blood substitutes Free Radic Biol Med 36 2004 685 697
59. A.K. Malhotra, M.E. Kelly, and P.R. Miller Resuscitation with a novel hemoglobin-based oxygen carrier in a Swine model of uncontrolled perioperative hemorrhage J Trauma 54 2003 915 924
60. E. von Dobschuetz, J. Hutter, and T. Hoffmann Recombinant human hemoglobin with reduced nitric oxide-scavenging capacity restores effectively pancreatic microcirculatory disorders in hemorrhagic shock Anesthesiology 100 2004 1484 1490
61. T.C. Resta, B.R. Walker, and M.R. Eichinger Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity J Appl Physiol 93 2002 1327 1336
62. K.E. Burhop, and M.P. Doyle The development and preclinical testing of a second generation recombinant hemoglobin solution, rHb2.0 for injection K. Messmer K.E. Burhop J. Hutter Microcirculatory effects of hemoglobin solutions 2004 Karger Basel 48 64
63. G.M. LaMuraglia, P.J. O'Hara, and W.H. Baker The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution J Vasc Surg 31 2000 299 308
64. J.S. Jahr A novel blood substitute: use of HBOC-201 (Hemopure) to decrease need for RBC: results of pivotal trial in orthopedic surgery patients Crit Care Med 29 SupplA 2001 S168
65. J.H. Levy, L.T. Goodnough, and P.E. Greilich Polymerized bovine hemoglobin solution as a replacement for allogeneic red blood cell transfusion after cardiac surgery: results of a randomized, double-blind trial J Thorac Cardiovasc Surg 124 2002 35 42
66. J. Sprung, J.D. Kindscher, and J.A. Wahr The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized single-blind study Anesth Analg 94 2002 799 808
67. J.S. Jahr, L.M. Stewart, and C. MacKenzie Pivotal phase III study: safety of polymerized bovine hemoglobin (HBOC-201, Hemopure) as compared to RBC in patients undergoing orthopedic surgery Anesthesiology 96 2002 A243
68. A.L. Rosen, S.A. Gould, and L.R. Sehgal Effect of hemoglobin solution on compensation to anemia in the erythrocyte-free primate J Appl Physiol 68 1990 938 943
69. J.S. Jahr, and N. Varma PolyHeme IDrugs 7 2004 478 482
70. S.A. Gould, E.E. Moore, and F.A. Moore Clinical utility of human polymerized hemoglobin as a blood substitute after acute trauma and urgent surgery J Trauma 43 1997 325 331
71. S.A. Gould, E.E. Moore, and D.B. Hoyt The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery J Am Coll Surg 187 1998 113 120
72. S.A. Gould, E.E. Moore, and D.B. Hoyt The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable J Am Coll Surg 195 2002 445 452
73. J.L. Carson, H. Noveck, and J.A. Berlin Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion Transfusion 42 2002 812 818
74. A. Zollinger, P. Hager, and T. Singer Extreme hemodilution due to massive blood loss in tumor surgery Anesthesiology 87 1997 985 987
75. D.C. Cheng Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery Can J Anaesth 48 4 Suppl 2001 S41 S48
76. S.E. Hill, L.I. Gottschalk, and K. Grichnik Safety and preliminary efficacy of hemoglobin raffimer for patients undergoing coronary artery bypass surgery J Cardiothorac Vasc Anesth 16 2002 695 702
77. D.C. Cheng, C.D. Mazer, and R. Martineau A phase II dose-response study of hemoglobin raffimer (Hemolink) in elective coronary artery bypass surgery J Thorac Cardiovasc Surg 127 2004 79 86
78. A.G. Greenburg, and H.W. Kim Hemolink study G: use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery J Am Coll Surg 198 2004 373 383 [discussion 384-5]
79. A.G. Tsai, K.D. Vandegriff, and M. Intaglietta Targeted O2 delivery by low-P50 hemoglobin: a new basis for O2 therapeutics Am J Physiol 285 2003 H1411 H1419
80. R. Wettstein, A.G. Tsai, and D. Erni Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters Crit Care Med 31 2003 1824 1830
81. D. Drobin, B.T. Kjellstrom, and E. Malm Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4) J Appl Physiol 96 2004 1843 1853
82. R.M. Winslow alpha-alpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang 79 2000 1 20
83. M. Jamnicki, R. Kocian, and P. van der Linden Acute normovolemic hemodilution: physiology, limitations, and clinical use J Cardiothorac Vasc Anesth 17 2003 747 754
84. J.G. Riess Oxygen carriers ("blood substitutes"): raison d'etre, chemistry, and some physiology Chem Rev 101 2001 2797 2920
85. J.A. Wahr, A. Trouwborst, and R.K. Spence A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients Anesth Analg 82 1996 103 107
86. P.T. Leese, R.J. Noveck, and J.S. Shorr Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers Anesth Analg 91 2000 804 811
87. O.P. Habler, M.S. Kleen, and J.W. Hutter IV perflubron emulsion versus autologous transfusion in severe normovolemic anemia: effects on left ventricular perfusion and function Res Exp Med 197 1998 301 318
88. W.L. Holman, R.D. Spruell, and E.R. Ferguson Tissue oxygenation with graded dissolved oxygen delivery during cardiopulmonary bypass J Thorac Cardiovasc Surg 110 1995 774 785
89. M. Paxian, H. Rensing, and K. Geckeis Perflubron emulsion in prolonged hemorrhagic shock: influence on hepatocellular energy metabolism and oxygen-dependent gene expression Anesthesiology 98 2003 1391 1399
90. M. Paxian, S.A. Keller, and T.T. Huynh Perflubron emulsion improves hepatic microvascular integrity and mitochondrial redox state after hemorrhagic shock Shock 20 2003 449 457
91. R.J. Noveck, E.J. Shannon, and P.T. Leese Randomized safety studies of intravenous perflubron emulsion. II. Effects on immune function in healthy volunteers Anesth Analg 91 2000 812 822
92. R.J. Frumento, L.M. Mongero, and Y. Naka Preserved gastric tonometric variables in cardiac surgical patients administered intravenous perflubron emulsion Anesth Analg 94 2002 809 814
93. H. Sakai, K. Hamada, and S. Takeoka Physical properties of hemoglobin vesicles as red cell substitutes Biotechn Progr 12 1996 119 125
94. H. Sakai, S. Takeoka, and R. Wettstein Systemic and microvascular responses to hemorrhagic shock and resuscitation with Hb vesicles Am J Physiol 283 2002 H1191 H1199
95. D. Erni, R. Wettstein, and S. Schramm Normovolemic hemodilution with Hb vesicle solution attenuates hypoxia in ischemic hamster flap tissue Am J Physiol 284 2003 H1702 H1709
96. th, and S.L. Stramer Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population Transfusion 42 2002 975 979
97. Innerhofer Immunomodulation mechanisms following transfusion of allogeneic and autologous erythrocyte concentrates Infus Ther Transfus Med 29 2002 118 121
98. L.O. Sillerud, A. Caprihan, and N. Berton Efficacy of recombinant human Hb by 31P-NMR during isovolemic total exchange transfusion J Appl Physiol 86 1999 887 894